I am an independent consultant specializing in commercial due diligence, growth strategy, and value creation, with a focus on life sciences, pharma, and healthcare. My work is anchored in analytical rigor, sector fluency, and actionable recommendations that drive investor confidence.
Over the past decade I’ve supported top-tier investors on transactions across North America. My domain expertise spans:
– Pharma Tech: EDC, eCOA, eTMF, CTMS, eConsent, DTC, site management tools, and safety/pharmacovigilance platforms.
– Clinical Operations: SMOs, central and specialty labs, biosample logistics, and kit vendors.
– Pharma Services: CROs, bioanalytical testing, companion diagnostics, MSL providers/field-based medical affairs, HEOR firms, RWE providers, patient recruitment platforms, and market access consultancies.
– Healthcare IT: EHRs, RCM, practice management systems, virtual care platforms, care coordination tools, and patient engagement solutions.
Typical engagements include:
• Commercial due diligence: market sizing, competitive landscape analysis, voice-of-customer insights, growth trajectory validation, and risk/opportunity assessment.
• Value creation strategy: whitespace identification, pricing and margin optimization, and new market entry planning.
• Post-close support: strategic planning, bolt-on acquisition identification, interim strategy roles, and execution of growth initiatives.
Veritux independent consultants are available where you need them – in all major markets and every global region.
